Oropharynx Squamous Cell Carcinoma
specificStage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)
11
Centers
1
Active Trials
—
Cancer Funding
Top Centers for Oropharynx Squamous Cell Carcinoma(11)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive High-Volume Research Center | 75.0 |
| 2 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive | 52.5 |
| 3 | University of Michigan Rogel Cancer CenterAnn Arbor, MI NCI Comprehensive | 52.5 |
| 4 | UPMC Hillman Cancer CenterPittsburgh, PA NCI Comprehensive | 52.5 |
| 5 | UC San Diego Moores Cancer CenterLa Jolla, CA NCI Comprehensive | 52.5 |
| 6 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive | 52.5 |
| 7 | Moffitt Cancer CenterTampa, FL NCI Comprehensive | 52.5 |
| 8 | Dartmouth Cancer CenterLebanon, NH NCI Comprehensive | 52.5 |
| 9 | Stephenson Cancer CenterOklahoma City, OK NCI Clinical | 52.5 |
| 10 | Boston University Cancer CenterBoston, MA | 52.5 |
| 11 | Karmanos Cancer InstituteDetroit, MI NCI Comprehensive | 52.5 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →